American Brain Tumor Association’s 2013 Patient & Family Conference Highlights Emerging Research

Leading researchers to discuss the movement toward patient-centered research and personalized brain tumor treatments.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“This meeting is one example of the ways in which the ABTA brings researchers and patients together to discuss the impact of the disease and approaches to changing brain tumor research outcomes.”

Chicago, IL (PRWEB) June 25, 2013

The American Brain Tumor Association’s 2013 Patient & Family Conference, taking place in Chicago on Fri., July 26 and Sat., July 27, focuses on the medical, rehabilitative, social and wellness needs of brain tumor patients and their caregivers as well as brain tumor research updates.

“There is a growing movement in science toward patient-centric research – placing the patient, who is living with the disease, at the center of the investigative setting. Patients and caregivers are assuming greater roles in the formation of both initial research questions and clinical trial designs,” said Elizabeth Wilson, ABTA president and CEO. “This meeting is one example of the ways in which the ABTA brings researchers and patients together to discuss the impact of the disease and approaches to changing brain tumor research outcomes.”

As the first national non-profit organization to fund brain tumor research, the ABTA has been credited with seeding the modern day research field through its funding of successive generations of researchers since the 1970s. The organization’s research grants are awarded with a unique condition of support: study findings are reported to patients and caregivers directly impacted by the disease. This is often the first opportunity for scientists to have a conversation with someone living with the disease, and for patients to better understand research and research outcomes challenges.

Day one of the meeting program includes an overview of the advances in brain tumor research and areas of emerging interest, and a poster session during which researchers share their study findings with attendees. The second day of the meeting integrates holistic approaches to wellness and strategies for patients and caregivers adjusting to and living with the diagnosis, its treatments, and brain tumor survivorship.

The 2013 American Brain Tumor Association Patient & Family Conference is being held at the Renaissance Chicago O’Hare Suites Hotel, 8500 W. Bryn Mawr Ave. in Chicago. To register, visit http://www.braintumorconference.org or call 800-886-ABTA (2282).

Sponsors for the 2013 Patient & Family Conference include Genentech, Inc., Northwest Biotherapeutics, The University of Chicago Medical Center, Alexian Brothers Neuroscience Institute, Cleveland Clinic Brain Tumor and Neuro-Oncology Center, NorthShore University HealthSystem, Novocure Inc., Procure Proton Therapy Center, The Northwestern Brain Tumor Institute and The Ohio State University.

ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION
Founded in 1973, the American Brain Tumor Association was first and is now the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups. For more information, visit http://www.abta.org.


Contact

  • Kate Butler
    ABTA
    773-577-8792
    Email
  • Garett Auriemma
    ABTA
    773-577-8791
    Email